Prescription drug · ANDA
Mycophenolate Mofetil NDC 60219-1595
Mycophenolate mofetil 200 mg/mL · Powder, For suspension · Oral · Amneal Pharmaceuticals NY LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 60219-1595-2 | 6021915950260219159502 | 1 BOTTLE, PLASTIC in 1 CARTON (60219-1595-2) / 225 mL in 1 BOTTLE, PLASTICMarketed from Mar 21, 2024 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Mycophenolate Mofetil
- Generic name (nonproprietary)
- mycophenolate mofetil
- Active ingredients
- Mycophenolate mofetil — 200 mg/mL
- Dosage form
- Powder, For suspension
- Route
- Oral
- Labeler
- Amneal Pharmaceuticals NY LLCNDC labeler code 60219
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214871
- Marketing start
- Listing expires
- Identifiers
- Product ID 60219-1595_545a5c62-f746-4667-91ec-68673bfa787fSPL ID 545a5c62-f746-4667-91ec-68673bfa787fSPL set ID 5d7f7b88-79e3-4a56-a9f3-796c28049a60RxCUI 311880UNII 9242ECW6R0
- Pharmacologic class
- Antimetabolite Immunosuppressant
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N460219159502followed by a unit qualifier and the quantityPackage 60219-1595-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective . This label includes a boxed warning.
Indications (excerpt from the label)
Mycophenolate mofetil for oral suspension is indicated for the prophylaxis of organ rejection, in adult and pediatric recipients 3 months of age and older of allogeneic kidney [see Clinical Studies (14.1) ] , heart [see Clinical Studies (14.2) ] or liver transplants [see Clinical Studies (14.3) ] , in combination with other immunosuppressants. Mycophenolate mofetil for oral suspension is an antimetabolite immunosuppressant indicated for the prophylaxis of organ rejection in adult and pediatric recipients 3 months of age and older of allogeneic kidney, heart or liver transplants, in combination with other immunosuppressants. (1)
Excerpt only. Read the full label for complete information.
About NDC 60219-1595
- What is NDC 60219-1595?
- 60219-1595 is the product NDC for Mycophenolate Mofetil, Mycophenolate mofetil 200 mg/mL powder, for suspension, listed with the FDA by Amneal Pharmaceuticals NY LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Mycophenolate Mofetil.
- What is the active ingredient?
- Mycophenolate mofetil.
- Who is the labeler?
- Amneal Pharmaceuticals NY LLC, NDC labeler code 60219. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Mycophenolate Mofetil?
- 57 other product NDCs are listed under this name. See all Mycophenolate Mofetil NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Mycophenolate Mofetil products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| mycophenolate mofetil | Mycophenolate mofetil 250 mg/1 | CapsuleOral | Cardinal Health 107, LLC | 55154-0161 | 55154-0161-00 |
| Mycophenolate Mofetil | Mycophenolate mofetil 200 mg/mL | Powder, For suspensionOral | Strides Pharma Science Limited | 64380-899 | 64380-0899-00 |
| Mycophenolate Mofetil | Mycophenolate mofetil 200 mg/mL | Powder, For suspensionOral | QUAGEN PHARMACEUTICALS LLC | 70752-294 | 70752-0294-60 |
| Mycophenolate Mofetil | Mycophenolate mofetil 200 mg/mL | Powder, For suspensionOral | NorthStar Rx LLC | 72603-751 | 72603-0751-01 |
| mycophenolate mofetil | Mycophenolate mofetil 250 mg/1 | CapsuleOral | Major Pharmaceuticals | 0904-7466 | 00904-7466-61 |
| Mycophenolate Mofetil | Mycophenolate mofetil 250 mg/1 | CapsuleOral | Wuxi Fortune Pharmaceutical Co.,Ltd. | 65050-2073 | 65050-2073-00 |
| Mycophenolate mofetil | Mycophenolate mofetil 500 mg/1 | Tablet, Film coatedOral | REMEDYREPACK INC. | 70518-4377 | 70518-4377-00 |
| Mycophenolate mofetil | Mycophenolate mofetil 250 mg/1 | CapsuleOral | AvKARE | 73190-009 | 73190-0009-0173190-0009-50 |
| Mycophenolate mofetil | Mycophenolate mofetil 500 mg/1 | Tablet, Film coatedOral | AvKARE | 73190-010 | 73190-0010-0173190-0010-50 |
| mycophenolate mofetil | Mycophenolate mofetil 250 mg/1 | CapsuleOral | American Health Packaging | 60687-885 | 60687-0885-01 |
Other NDCs under ANDA 214871
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Mycophenolate Mofetil | Mycophenolate mofetil 200 mg/mL | Powder, For suspensionOral | Amneal Pharmaceuticals LLC | 69238-1595 |